BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹5,987 Cr | ₹5,488 Cr | ₹6,231 Cr | ₹3,573 Cr | ₹2,058 Cr |
What is the latest Sundry Debtors ratio of BIOCON ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹5,987 Cr |
| Mar2025 | ₹5,488 Cr |
| Mar2024 | ₹6,231 Cr |
| Mar2023 | ₹3,573 Cr |
| Mar2022 | ₹2,058 Cr |
How is Sundry Debtors of BIOCON Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,987 Cr | 9.09 | |
| Mar2025 | ₹5,488 Cr | -11.92 | |
| Mar2024 | ₹6,231 Cr | 74.37 | |
| Mar2023 | ₹3,573 Cr | 73.61 | |
| Mar2022 | ₹2,058 Cr | - | |
Compare Sundry Debtors of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹60,445.6 Cr | -2.7% | -7.6% | 4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.7% |
-7.6% |
4.3% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses